The U.S. Food and Drug Administration has approved a UK company's cannabis-based medicine for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet...

University of Sydney's Lambert Initiative for Cannabinoid Therapeutics is continuing its call for Australians to get involved in the Cannabis As Medicine Survey (CAMS)...

Australia's Bioxyne Limited (ASX: BXN) has announced its subsidiary, Breathe Life Sciences (BLS), has manufactured and delivered Australia’s first pharmaceutical-grade cannabis pastilles - also...

Australia's Cann Group (ASX:CAN) has entered into an agreement aiming to accelerate registration of a Schedule 3, over-the-counter cannabidiol (CBD) medicine in Australia.While it...